Torrent Pharma Shares

• 

  Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir

  Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday

• 

  Torrent Pharma Surges 10% After Profit Rises 49% In June Quarter

  Torrent Pharma's revenue from US operations declined 1 per cent to Rs 373 crore while constant currency sales came in at $47 million.

• 

  Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why

  Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.

• 

  Trading Calls: Buy ONGC, Torrent Pharma, Mirza International, Say Experts

  BSE Sensex and Nifty were under pressure on Friday dragged down by Axis Bank on disappointing results. Investors also remained cautious ahead of Donald Trump's inauguration as the US president later in the day.

• 

  Torrent Pharma Q2 Net Falls 59 % To Rs 207 Crore

  The company had posted a net profit after tax, minority interest and share of profit of associates of Rs 509 crore in July-September 2015-16, boosted by launch of a new product in the US.

• 

  Torrent Pharma Shares Tumble 11% As Q2 Net Dips

  The drug firm yesterday reported a 59.33 per cent dip in consolidated net profit to Rs 207 crore for the second quarter.

• 

  Torrent Pharma Profit Falls 55% In Q1, Shares Hit

  Torrent Pharma reported a net profit of Rs 292 crore in Q1 compared to a net profit of Rs 650 crore in the corresponding quarter of last fiscal on the back of 50 per cent decline in revenue from US.

• 

  Torrent Pharma Q1 Net Slumps 55% To Rs 292 Crore, US Business Hurts

  Drug firm Torrent Pharmaceuticals on Wednesday reported 55.07 per cent fall in consolidated net profit at Rs 292 crore for the June quarter due to a dip in company's US business.

• 

  Torrent Pharma To Acquire Glochem's Vizag-Based Facility

  Torrent Pharmaceuticals on Thursday said it has inked a pact to acquire Glochem Industries' Vizag-based manufacturing facility along with some drug master files.

• 

  Why Torrent Pharma Shares Slumped Despite Stellar Q4

  Torrent Pharma also guided for higher research and development expenditure going forward, which is likely to dent its profitability, analysts said. The management expects R&D costs to scale up to 8 per cent in FY17 from 4 per cent last fiscal.

• 

  Torrent Pharma Posts Profit Of Rs 357 Crore In March Quarter

  Torrent Pharma on Monday reported a consolidated net profit of Rs 357 crore for the quarter ended March 31, mainly on account of robust sales in the US market.

• 

  Torrent Pharma Seeks Enabling Nod to Raise Rs 10,500 Crore

  The Ahmedabad-based drug firm Torrent Pharma is seeking enabling approvals from its shareholders to raise Rs 10,500 crore through issue of shares and other securities to fund its growth activity.

• 

  Sensex Falls 286 Points on Selloff in Metal Shares

  UPL, Sun TV Network, MRPL, Jidal Steel, NALCO, Torrent Pharma, JSW Steel and Glenmark were among the losers from the mid-cap space, down 3-4.6 per cent each.

• Torrent Pharma Board Approves Zyg Amalgamation

  Torrent Pharmaceuticals on Thursday said its board has given nod to the scheme of amalgamation of its subsidiary Zyg Pharma with the company.

• 

  Elder Pharma Surges 16% on Asset Sale Plans

  Last year, Elder Pharma had sold its branded domestic formulations business in India and Nepal to Torrent Pharmaceuticals for Rs 2,004 crore.